Sara Hamon

4.9k total citations
71 papers, 2.3k citations indexed

About

Sara Hamon is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Pharmacology. According to data from OpenAlex, Sara Hamon has authored 71 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cellular and Molecular Neuroscience, 16 papers in Molecular Biology and 16 papers in Pharmacology. Recurrent topics in Sara Hamon's work include Neurotransmitter Receptor Influence on Behavior (16 papers), Cannabis and Cannabinoid Research (16 papers) and Lipoproteins and Cardiovascular Health (10 papers). Sara Hamon is often cited by papers focused on Neurotransmitter Receptor Influence on Behavior (16 papers), Cannabis and Cannabinoid Research (16 papers) and Lipoproteins and Cardiovascular Health (10 papers). Sara Hamon collaborates with scholars based in United States, France and China. Sara Hamon's co-authors include Jürg Ott, David A. Nielsen, Peter J. Francis, Mary Jeanne Kreek, Michael L. Klein, Thomas R. Kosten, Poulabi Banerjee, Richard G. Weleber, Ann Ho and Dennis W. Schultz and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Circulation and Gastroenterology.

In The Last Decade

Sara Hamon

70 papers receiving 2.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sara Hamon United States	29	681	495	447	359	341	71	2.3k
Stephen Nussey United Kingdom	26	369 0.5×	352 0.7×	291 0.7×	498 1.4×	85 0.2×	65	2.5k
Michael Elashoff United States	28	1.4k 2.0×	51 0.1×	573 1.3×	265 0.7×	494 1.4×	47	3.2k
Matt J. Neville United Kingdom	31	911 1.3×	111 0.2×	269 0.6×	44 0.1×	248 0.7×	60	2.8k
Xiaohong Jin China	26	787 1.2×	82 0.2×	187 0.4×	77 0.2×	82 0.2×	91	2.2k
Kenneth Opeskin Australia	29	783 1.1×	82 0.2×	235 0.5×	102 0.3×	667 2.0×	80	2.1k
Bogdan Marek Poland	26	455 0.7×	184 0.4×	182 0.4×	85 0.2×	30 0.1×	166	2.0k
David Matthews United Kingdom	22	456 0.7×	809 1.6×	334 0.7×	645 1.8×	16 0.0×	34	2.7k
Erifili Hatziagelaki Greece	23	534 0.8×	95 0.2×	252 0.6×	52 0.1×	41 0.1×	66	1.8k
Radu Tănăsescu United Kingdom	26	370 0.5×	35 0.1×	185 0.4×	120 0.3×	258 0.8×	100	3.1k
Marcus Koch Canada	36	668 1.0×	51 0.1×	88 0.2×	136 0.4×	370 1.1×	117	4.1k

Countries citing papers authored by Sara Hamon

Since Specialization

Citations

This map shows the geographic impact of Sara Hamon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sara Hamon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sara Hamon more than expected).

Fields of papers citing papers by Sara Hamon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sara Hamon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sara Hamon. The network helps show where Sara Hamon may publish in the future.

Co-authorship network of co-authors of Sara Hamon

This figure shows the co-authorship network connecting the top 25 collaborators of Sara Hamon. A scholar is included among the top collaborators of Sara Hamon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sara Hamon. Sara Hamon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wipperman, Matthew F., Kaitlyn Gayvert, Amanda Atanasio, et al.. (2024). Differential modulation of allergic rhinitis nasal transcriptome by dupilumab and allergy immunotherapy. Allergy. 79(4). 894–907. 12 indexed citations

Devalaraja‐Narashimha, Kishor, Peter J. Ehmann, Cong Huang, et al.. (2022). Association of complement pathways with COVID-19 severity and outcomes. Microbes and Infection. 25(4). 105081–105081. 9 indexed citations

Wipperman, Matthew F., Andreja Avberšek, Robin R. Deterding, et al.. (2022). A pilot study of the Earable device to measure facial muscle and eye movement tasks among healthy volunteers. arXiv (Cornell University). 1 indexed citations

Adam, Rene C., Poulabi Banerjee, Sara Hamon, et al.. (2020). Angiopoietin-like protein 3 governs LDL-cholesterol levels through endothelial lipase-dependent VLDL clearance. Journal of Lipid Research. 61(9). 1271–1286. 124 indexed citations

Tóth, Peter P., Sara Hamon, Steven R. Jones, et al.. (2016). Effect of alirocumab on specific lipoprotein non-high-density lipoprotein cholesterol and subfractions as measured by the vertical auto profile method: analysis of 3 randomized trials versus placebo. Lipids in Health and Disease. 15(1). 28–28. 39 indexed citations

Kastelein, John J.P., Gisle Langslet, Paul N. Hopkins, et al.. (2016). EFFICACY OF ALIROCUMAB IN 1,191 PATIENTS WITH A WIDE SPECTRUM OF MUTATIONS IN GENES CAUSATIVE FOR FAMILIAL HYPERCHOLESTEROLEMIA. Journal of the American College of Cardiology. 67(13). 1864–1864. 1 indexed citations

Thuvander, Liane, et al.. (2014). Early integration of the user’s perspective in the renovation process: Experiences from an “In-depth Dialogue Process with Residents” in rental flats from the 1950s. Chalmers Publication Library (Chalmers University of Technology). 1 indexed citations

Krauss, Ronald M., Poulabi Banerjee, Sara Hamon, et al.. (2014). Abstract 15525: Alirocumab, a Fully Human Monoclonal Antibody to Proprotein Convertase Subtilisin/kexin Type 9, and Its Effects on Lipoprotein Subfractions Determined by Ion Mobility. Circulation. 130. 1 indexed citations

Koren, Michael J., Dean J. Kereiakes, Deborah A. Winegar, et al.. (2014). EFFECTS OF ALIROCUMAB, A FULLY HUMAN MONOCLONAL ANTIBODY TO PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9, ON LIPOPROTEIN PARTICLE CONCENTRATIONS DETERMINED BY NUCLEAR MAGNETIC RESONANCE: SUBSTUDY OF A RANDOMIZED DOUBLE-BLIND PHASE II CLINICAL TRIAL. Journal of the American College of Cardiology. 63(12). A1373–A1373. 2 indexed citations

10.

Anastasio, Noelle C., Scott D. Lane, Robert G. Fox, et al.. (2014). Variation within the serotonin (5-HT) 5-HT2C receptor system aligns with vulnerability to cocaine cue reactivity. Translational Psychiatry. 4(3). e369–e369. 33 indexed citations

11.

Shorter, Daryl, et al.. (2013). Pharmacogenetic randomized trial for cocaine abuse: Disulfiram and α1A-adrenoceptor gene variation. European Neuropsychopharmacology. 23(11). 1401–1407. 22 indexed citations

12.

Molnár, János, et al.. (2013). Role of Anemia in Home Oxygen Therapy in Chronic Obstructive Pulmonary Disease Patients. American Journal of Therapeutics. 22(5). 361–366. 8 indexed citations

13.

Levran, Orna, Einat Peles, Sara Hamon, et al.. (2011). CYP2B6SNPs are associated with methadone dose required for effective treatment of opioid addiction. Addiction Biology. 18(4). 709–716. 88 indexed citations

14.

Ho, Ann, et al.. (2011). Effect of ethnicity, gender and drug use history on achieving high rates of affirmative informed consent for genetics research: impact of sharing with a national repository. Journal of Medical Ethics. 37(6). 374–379. 7 indexed citations

15.

Yuferov, Vadim, David A. Nielsen, Orna Levran, et al.. (2010). Tissue-specific DNA methylation of the human prodynorphin gene in post-mortem brain tissues and PBMCs. Pharmacogenetics and Genomics. 21(4). 185–196. 36 indexed citations

16.

Proudnikov, Dmitri, Thomas Kroslak, J.C. Sipe, et al.. (2009). Association of polymorphisms of the cannabinoid receptor (CNR1) and fatty acid amide hydrolase (FAAH) genes with heroin addiction: impact of long repeats of CNR1. The Pharmacogenomics Journal. 10(3). 232–242. 36 indexed citations

17.

Klein, Michael L., Peter J. Francis, Bernard Rosner, et al.. (2008). CFH and LOC387715/ARMS2 Genotypes and Treatment with Antioxidants and Zinc for Age-Related Macular Degeneration. Ophthalmology. 115(6). 1019–1025. 128 indexed citations

18.

Kardia, Sharon L. R., Yan V. Sun, Sara Hamon, et al.. (2007). Interactions between the adducin 2gene and antihypertensive drug therapies in determining blood pressure in people with hypertension. BMC Medical Genetics. 8(1). 61–61. 9 indexed citations

19.

Francis, Peter J., Sarah J. George, Dennis W. Schultz, et al.. (2007). The <i>LOC387715 </i>Gene, Smoking, Body Mass Index, Environmental Associations with Advanced Age-Related Macular Degeneration. Human Heredity. 63(3-4). 212–218. 67 indexed citations

20.

Kammerer, Stefan, Lora Hamuro, Yuliang Ma, et al.. (2003). Amino acid variant in the kinase binding domain of dual-specific A kinase-anchoring protein 2: A disease susceptibility polymorphism. Proceedings of the National Academy of Sciences. 100(7). 4066–4071. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact